Comprehensive Pan-cancer Analysis of CMPK2 as Biomarker and Prognostic Indicator for Immunotherapy
CONCLUSION: Our analysis preliminarily describes the complex function of CMPK2 in cancer progression and immune microenvironment highlighting its potential as a diagnostic and therapeutic target for immunotherapy.PMID:38486392 | DOI:10.2174/0115680096281451240306062101
Source: Current Cancer Drug Targets - Category: Cancer & Oncology Authors: Jingyuan Luo Qianyue Zhang Shutong Wang Luojie Zheng Jie Liu Yuchen Zhang Yingchen Wang Ranran Wang Zhigang Xiao Zheng Li Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Cancer of the Uterus | Carcinoma | Endometrial Cancer | Eye Cancers | Genetics | Immunotherapy | Lupus | Melanoma | Mitochondrial Disease | Skin | Skin Cancer | Study | Urology & Nephrology | Uveal Melanoma